Dr. Bonnie Ky is an Associate Professor of Medicine and Epidemiology and physician scientist at the University of Pennsylvania. She leads a highly active NIH-funded translational research program in cardio-oncology and is the PI of multiple investigator-initiated cohort studies and clinical trials focused on the study of the cardiotoxic effects of doxorubicin, trastuzumab, sunitinib, and radiation therapy in breast, renal cell, and lung cancers, and lymphoma patients. Her programmatic objectives are to understand how to improve cardiovascular outcomes in cancer patients by determining individual patient risk, through detailed phenotyping of clinical characteristics, biologic markers, and echocardiography-derived measures of myocardial mechanics and function.
She serves as the Director for the Penn Center for Quantitative Echocardiography and is the founding Director of the Penn Cardio-Oncology Center of Excellence. She is an invited member of many cardio-oncology expert consensus and research groups within the NIH, FDA, American Society of Clinical Oncology, American College of Cardiology, American Heart Association, and European Society of Cardiology focused on advancing our understanding of cardiovascular disease in the growing cancer population. She serves on the Editorial Board of Circulation, Circulation Heart Failure and the Journal of the American College of Cardiology. She is an inducted member of the American Society of Clinical Investigation.
